Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Netherton Syndrome
Netherton Syndrome
Microbiome Report for Week Ending 4/13/19
CP Wire
Thu, 04/18/19 - 10:33 pm
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Microbiome Report for Week Ending 4/13/19
Thu, 04/18/19 - 10:31 pm
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
CP Wire
Wed, 04/10/19 - 11:30 pm
Azitra
Netherton Syndrome
microbiome
skin microbiome
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
Wed, 04/10/19 - 08:12 pm
Azitra
Netherton Syndrome
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
CP Wire
Mon, 08/27/18 - 09:54 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
Mon, 08/27/18 - 09:12 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome